Avivagen Inc V.VIV

Alternate Symbol(s): VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

TSXV:VIV - Post by User

Avivagen Inc > New Zealand

<< Previous

Bullboard Posts

Next >>

Comment by StoneMan45on Aug 08, 2020 11:49am

108 Views

Post# 31382729

RE:New Zealand

JFYI
with the 3 extremely positive trials done demonstrating Oxc betas benefits to dairy production and knowing that Brazil represents the 4th largest dairy producer at around 36 billion kg of milk / yr. New zealand is 8th at around 19 billion kg / yr , can't help but see Avivagen is on the cusp of serious growth. Even if you were look at the dairy sector as solo but it isn't . The benefits to swine and poultry are well demostrated. They are traversing into the human market as the action of OxC beta is relevant and could be significant to the current covid situation. Suffice it to say I'm happy with where things are heading for Avivagen

the latest test in Mexico
https://www.avivagen.com/avivagen-announces-increase-in-north-american-oxc-betatm-livestock-order-following-successful-dairy-field-tests/

Of significant note, a large and well known global dairy processor that purchases the farm’s milk recognized the farm with three separate financial awards for the improvements in milk yield, quality, and reduced bacterial levels achieved during the test.

the dairy trial in New Zealand that resulted in another patent filing
https://www.avivagen.com/avivagen-announces-positive-results-from-new-zealand-oxc-betatm-livestock-dairy-trial-for-use-against-sub-clinical-mastitis/

“We have assessed a number of compounds in terms of their ability to help clear sub clinical mastitis, and this is the first time we have seen a positive effect.”” said Scott McDougall, BSc(Vet), BVSc, PhD; Managing Director of Cognsoco.

the dairy trial done by COFCO in China
https://web.tmxmoney.com/article.php?newsid=6770699447341440&qm_symbol=VIV

Dr. Hongyu Zhang, Assistant General Manager and Product Director at COFCO Biotech and the scientist responsible for oversight of the trial commented: “These results demonstrate that dietary supplementation with OxC-beta benefited milk quality. COFCO Biotech considers these findings positive and we see strong potential for OxC-beta in the Chinese dairy industry.

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition